CIBC reissued their market perform rating on shares of HEXO (NASDAQ:HEXO) in a research note issued to investors on Tuesday, June 25th, FirstToMarketsRatingsTable reports.
Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group started coverage on in a research note on Monday, February 25th. They set a buy rating for the company. Bank of America set a $10.00 price objective on HEXO and gave the company a buy rating in a research note on Thursday, June 13th. Zacks Investment Research raised HAYS PLC/ADR from a sell rating to a hold rating in a research note on Tuesday, June 18th. Oppenheimer set a $14.00 price target on ADMA Biologics and gave the stock a buy rating in a report on Tuesday, June 25th. Finally, AltaCorp Capital reaffirmed an outperform rating on shares of HEXO in a report on Thursday, April 4th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of Hold and an average price target of $8.63.
Shares of NASDAQ HEXO traded down $0.10 during midday trading on Tuesday, hitting $5.00. The stock had a trading volume of 2,293,636 shares, compared to its average volume of 3,477,730. HEXO has a 1 year low of $3.02 and a 1 year high of $8.40. The company’s 50 day simple moving average is $5.65.
HEXO (NASDAQ:HEXO) last posted its earnings results on Thursday, June 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the